4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-19-046031
General Counsel/Secretary bought 5,000 shares at $1.02 ($5,100)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Leavitt Chase C. General Counsel/Secretary | 2019-08-13 | Purchase | +5,000 | $1.02 | $5,100 | 5,000 | D: show line 1 in the form |
| Open-market purchases · 5,000 sh · avg $1.02 · $5,100 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Leavitt Chase C. General Counsel/Secretary | 2019-07-31 | Grant or award · Employee Stock Option (Right to Buy) | +125,000 | 125,000 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…